Systematic Review of Tongxinluo Capsule on the Therapeutic Effect and Hemorheology of Patients with Transient Ischemic Attack
Table 1
Characteristics of the literature.
Study ID
Sample size
Female
Median age
Intervention
Treatment course
Outcomes
I/C
I
C
I
C
I
C
Chen Y, 2009
71/67
44/27
43/24
58.1 ± 8.9
59.6 ± 9.6
TXL + asprin + CT
Asprin + CT
4 weeks
①
Chen ZQ, 2007
35/28
26/19
15/13
NA
TXL + asprin + CT
Asprin + CT
30 days
①②
Hou ZQ, 2017
60/60
36/24
35/25
60.3 ± 4.6
61.5 ± 5.8
TXL + asprin + CT
Asprin + CT
1 month
①②③④⑤
Huan YL, 2008
35/30
20/15
18/12
59.2 ± 10.3
58.1 ± 10.3
TXL + asprin + CT
Asprin + CT
1 month
①
Li L, 2005
30/20
21/9
9/11
62.2 ± 10.5
61.7 ± 10.4
TXL + asprin + CT
Asprin + CT
10 days
①
LI Y, 2009
50/40
30/20
28/12
59.9 ± 9.3/
57.6 ± 8.4
TXL + asprin + CT
Asprin + CT
4 weeks
①②③⑥
Wang HW, 2008
60/30
NA
NA
TXL + asprin + CT
Asprin + CT
15 days
①
Wang Q, 2010
30/30
18/12
16/14
NA
TXL + asprin + CT
Asprin + CT
15 days
①
Xu WZ, 2015
20/20
12/8
11/9
63 ± 7.2
62 ± 6.7
TXL + asprin + CT
Asprin + CT
1 month
①
Yi TL, 2015
31/31
17/14
18/13
62.1 ± 7.8
64.2 ± 8.1
TXL + asprin + CT
Asprin + CT
14 days
①
Zhang YL, 2008
30/30
16/14
13/17
62.76 ± 7.49
61.73 ± 7.54
TXL + CT
Asprin + CT
14 days
①③④⑤⑥
Zhou Y, 2018
49/49
NA
56.71 ± 4.18
57.38 ± 4.29
TXL + asprin + CT
Asprin + CT
14 days
①③④⑤⑥
Note. I/C: intervention group and conventional treatment; ①efficient; ②fibrinogen; ③plasma specific viscosity; ④whole blood high shear viscosity; ⑤whole blood low shear viscosity; and ⑥plasma specific viscosity.
